chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Heart racing, facial redness/ flushing 7-8 hours after Vaccine given. Severe allergic reaction 10 days after vaccine given with redness of face, itching in face and arms, hives on arms, tightness in chest, felt SOA. Taken to ER by friend, given IV Benadryl, Provide and solumedrol with some relief. Then IM Epi given. Then RX of Provide, Prednisone, and Benadryl. Symptoms slowly improving over 10 days.
After almost 30 hours, after the second injection, And with only a soar arm, I began to experience low blood pressure. Over the course of the next  6 hours, my blood pressure plummeted to 82/63. I countered this by intaking large amounts of salt, and ultimately took my Diltiazem and some Tylenol PM.  Around 3 am my blood pressure returned to normal and currently holding steady at 118/83,  I am monitoring it throughout the day, but it seems stable.
vial undergo temperature excursions; The vial was initially stored in the refrigerator on 03 Oct 2022 and was administered on 11 Nov 2022.; No adverse event; Erroneously vaccinated  clients with expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Erroneously vaccinated  clients with expired vaccine), PRODUCT TEMPERATURE EXCURSION ISSUE (vial undergo temperature excursions), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 03 Oct 2022 and was administered on 11 Nov 2022.) and NO ADVERSE EVENT (No adverse event) in a 58-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 057F22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 11-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 11-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Erroneously vaccinated  clients with expired vaccine). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (vial undergo temperature excursions), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 03 Oct 2022 and was administered on 11 Nov 2022.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Erroneously vaccinated  clients with expired vaccine), PRODUCT TEMPERATURE EXCURSION ISSUE (vial undergo temperature excursions), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 03 Oct 2022 and was administered on 11 Nov 2022.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Erroneously vaccinated  clients with expired vaccine), PRODUCT TEMPERATURE EXCURSION ISSUE (vial undergo temperature excursions) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 03 Oct 2022 and was administered on 11 Nov 2022.).    No concomitant medications were reported.  It was reported that the patient was administered dose after 30 day use by date. The size of the vial was 2.5 ml. The vial was initially stored in the refrigerator on 03-Oct-2022 and was administered on 11-Nov-2022. Beyond use date was reported as 02-Nov-2022. The vial underwent temperature excursion. 9 days past expiry date the patient received the vaccine.   No treatment information was reported.   This case was linked to US-MODERNATX, INC.-MOD-2022-681180 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-681180:MOD22-030180 Master Case
Day after and following day I was bedridden with extreme vertigo. Called off work 2 days. Also extreme joint pain. Day 3 moderate vertigo. Day 4 it subsided by evening. But still slightly present day 5. Headache accompanied each day and lymph node swelling and pain under left armpit day 2-3.
Pt called hospital call center on 10/28/21 reporting adverse reactions/side effects after receiving Moderna third dose on 10/19/2021. Pt c/o worsening dizziness x2 days, headache, stomach cramping, and left ear pain.  Pt advised to go to ED for evaluaation.
Information has been received from a physician concerning a female patient who was vaccinated with a dose of GARDASIL (Lot # was not available) experienced severe headaches after receiving the vaccine.  The patient went to emergency room because of these headaches but it was not known if she was admitted to the hospital.  The patient sought unspecified medical attention.  Additional information has been requested. This is in follow-up to report(s) previously submitted on 02/13/09. Follow up information was received. On 05-Jan-2009 the 19 year old female was vaccinated with her first dose of GARDASIL (Lot # 660616/0570X, route not reported) into her right deltoid. Sometime between 05-JAN-2009 and 14-JAN-2009 the patient developed severe headaches. Subsequently the patient recovered from the severe headaches. The event was not disabling. Additional information has been requested.
Sore throat, very tired-sleepy. Didn't have a runny nose, lithargic. Warm to the touch (didn't take temp)
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 33-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 14Feb2021 at 12:00 as dose 1, single (Lot number: EN6201), in right arm and on 02Mar2021 at 15:00 as dose 2, single (Lot number: EN6204) at the age of 32 years, in right arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 20Nov2021 at 12:00 as dose 3 (booster), single (Batch/Lot number: unknown), in right arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications.  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "recovering" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: product=COVID 19 Treatment, brand=Paxlovid; (Jul2022) Negative, notes: After testing negative for 2 days; (Jul2022) strongly positive, notes: Began testing strongly positive using at home rapid tests; (27Jul2022) Unknown results, notes: covid rebound occurred. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Patient did not take any other medication in 2weeks. Patient had no know allergies. Patient treated with anti viral Paxlovid for COVID 19 Treatment from 18Jul2022 to 23Jul2022. After testing negative for 2 days, covid rebound occurred. Began testing strongly positive using at home rapid tests on 27Jul2022 at 09:00 AM. Mild head congestion only symptom.
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a adult patient who received SHINGRIX for prophylaxis. On 5th February 2019, the patient received SHINGRIX. On an unknown date, less than a week after receiving SHINGRIX, the patient experienced pain in arm, breast pain, feeling anxious, bad dreams and tension. On an unknown date, the outcome of the pain in arm, breast pain, feeling anxious, bad dreams and tension were unknown. It was unknown if the reporter considered the pain in arm, breast pain, feeling anxious, bad dreams and tension to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient received SHINGRIX 2 days before the date of reporting. The patient's arm was sore and so was the under arm into breast area. The patient was in anxious feeling, had horrible bad dreams and very uptight. The patient asked if this happened to anyone else.
Swollen warm (R) deltoid with red bumps surrounding area   Denies respiratory problems or any other symptoms
Dizzy difficult breathing. Hair loss, I felt like I was having a heart attack. It lasted for several weeks
Patient states: I woke up at 03:00 with a charlie horse in my right leg and it got worse and now it is in my right arm.  difficulty moving.
patient experienced one swollen finger and back pain 2 weeks post vaccination. patient consulted with family physician who cannot rule out if these were covid-19 vaccination related.
Initial unsolicited report received from a consumer on 20 Oct 2016. This case involves a 54-year-old male patient who was vaccinated with first dose of injection of INFLUENZA VACCINE (FLU SHOT) (batch number, expiry date, dose, dose in series, route and site of administration were not reported) on 15 Oct 2016. The patient's medical history and concomitant medications were not reported. On 15 Oct 2016, same day following the vaccination, the patient had flu like symptoms. The patient's laboratory data and corrective treatment was not reported. On 16 Oct 2016, the patient was recovered from flu like symptoms. List of documents held by sender: none.
19jul90 pt vax hepta B. 25jul90 pt ex visual disorder desc. as obstructing lines which lasted for one hr.  pt ex pressure on back of neck, achiness, slight temp, and extreme fatigue.
Roughly 12 hours after receiving booster vaccine of Moderna, patient awoke at 1 am after having fallen asleep and reported feeling cold. He was trembling uncontrollably unable to get warm. He went into a hot shower and subsequently lost consciousness for 10 - 15 seconds. His eyes rolled back in his head and he slumped onto the shower floor. After regaining consciousness, he continued to report he felt cold.
Max awoke disoriented, slurring his speech, and unable to maintain his balance enough to stand. He didn't realize anything was wrong and repeatedly said he needed to get ready for school. He was taken to the emergency room and evaluated for a possible stroke or other brain injury, as well as possible intoxication. Initially, he could not hold a conversation, but was able to do so within about an hour of waking, though his speech was still significantly slurred and he was providing incorrect information regarding when things had happened over the previous few days. After all the imaging was performed and acute causes of his symptoms were ruled out, it was decided that he should be transferred to the Hospital ER for additional observation and possible testing by pediatric neurology. This was about 5 hours after the start of his symptoms. At this point, his speech had improved - it was only mildly slurred but significantly slower than normal - and he could stand without as much assistance. He was still having significant short term memory issues and did not remember things he had been told throughout the day. He underwent a neuro exam at the second ER and then was admitted for observation.  Once in his room, an EEG was performed to look for possible seizure activity as an explanation for the symptoms. No seizure activity was seen. By late afternoon, the slurring had resolved. By the next morning, his other symptoms resolved as well, though he had very few memories of the previous day. He was released before noon that day and has not experienced any symptoms since. He was evaluated by his pediatrician one week later and has a follow-up appointment with pediatric neurology in October.
Alopecia areata on beard and back of head. I received 3 Pfizer vaccines for covid on 12/28/20, 01/18/21 and 09/28/21. I started to notice loss of hair on my beard about March 2021 and it progressed to take about 70% of my beard to date. I notice 2 spots on the back of my head where I lost hair in May 2021, which has progressed to about 15% of hair loss on my head to date.
Much pain in both arms and back.  Excessive sleep.   Had fever night of 2/20/21.   By noon of 2/21 fever had broke.  Temp. 99.5.  Still a bit sluggish.
Headaches. Have been treating with a neurologist and pain physicians since March with NO relief. Medications are not helping alleviate the pain.
Multiple outbreaks of a painful rash, skin issues and bronchitis; Multiple outbreaks of a painful rash, skin issues and bronchitis; Multiple outbreaks of a painful rash, skin issues and bronchitis; Information has been received regarding a case in litigation from a lawyer and referred to a patient of unknown age and gender. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On or around 24-FEB-2015, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (dose, route, lot# and expiration date were not reported) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). Shortly after receiving zoster vaccine live (ZOSTAVAX), the patient suffered multiple outbreaks of a painful rash, skin issues and bronchitis. As a result of these symptoms, the patient was seen and treated by medical providers and was still under their care. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient's symptoms had resulted in physical limitations not present prior to using the product. The patient also experienced mental and emotional distress due to resulting physical limitations and seriousness of the patient's condition. As a result of the manufacturer, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), the patient sustained severe and permanent personal injuries. Further, as a tragic consequence of zoster vaccine live (ZOSTAVAX), the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient had suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the events was considered as not recovered. The causality assessment between all the events and zoster vaccine live (ZOSTAVAX) was considered as related by the lawyer.    The lawyer considered all the events to be disability.
Patient was walking outside after waiting 20 minutes in observation, got dizzy and fell on the sidewalk landing on her right knee. Patient right knee is swollen, tender to the touch, upon palpation; no crepitis, deformity, bleeding noted. Patient reports pain to right knee is 2/10.  Patient brought to EMS room by staff. Patient was in a wheelchair. Knee is yellow, black and blue.
This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, concomitant medication and drug reactions or allergies was reported. On 01-JUL-2016, the patient was vaccinated with an improperly stored dose of (Oka/Merck) VARIVAX once, subcutaneously, lot # M004326, expiration date 25-JAN-2018 (strength, dose and anatomical location were not provided). No adverse effects were reported. It was reported that the patient did not discontinue the therapy with (Oka/Merck) VARIVAX. Additional information has been requested.
2 days, hard, red, warm, 7cm on right thigh 3cm on left thigh.
roar in ears for 3 days; very weak (speed up heartbeat & flutter); sharp pain in lower rt abod (required x-ray) took no high blood pressure med for 3 wks; cold sx-raw throat-chest congestion-cough;
hives and itchy skins usually at night from 10/23/2021 until now (1/14/2022)
Headache; Severe chills; fever; Lack of energy; hair loss; This is a spontaneous report from a contactable consumer. This contactable consumer reported for her husband. A male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number; EN6205) intramuscular on 01Mar2021 at 10:50 am at single dose on right arm for covid-19 immunisation. Patient's medical history included ongoing sinus issues with onset date as adult, all my life, no smoking-mild COPD from 2015; pertinent details; N/A (chronic obstructive pulmonary disease), covid-19 from an unknown date in Nov2020. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number; EM9810) intramuscular on 08Feb2021 at 11:00 am at single dose on right arm for covid-19 immunisation. Relevant test was reported as none. Patient's concomitant medications were reported as none. Patient experienced headache, severe chills, lack of energy and hair loss on an unknown date. Patient's wife reported that the severe side effects with 1st shot side effects were similar with 2nd shot but not as severe. 'My husband got the same 2 shots (Pfizer)- just an FYI- No side effects 1st shot but slight headache. His second shot he had severe effects. Headache, severe chills, fever, lack of energy. After 2nd shot, he did take an Advil but no Benadryl. After both shots, my husband noticed hair loss- more than usual. It is 16Mar2021 and it is slowing up. The outcome of events was unknown and for alopecia was recovering.  Information on the lot/batch number has been requested.
Thought it would be useful to report these side effects from the second SHINGRIX shot, which surprised me by being worse than the first. The first time I just felt pain and swelling at the site and headache-y and tired. After the second shot, I also had flu-like symptoms: generalized muscle aches, extreme tiredness/weakness, belly pain, diarrhea, headache, upset stomach, chills. Worst of the symptoms passed after about 24 hours. Received the shot on April 18.
I received a phone call from the persons work place. They reported that she had a seizure at 2:00 PM this afternoon. Prior to the seizure they said that she was "feeling off", "jittery", and "misfiring".  The RN that notified me said that they were checking on her every hour and the last check in was at 1:00 PM. She went to check on her at 2:00 PM when she found her in the hallway very pale/gray, bradycardic, and hypotensive. The nurse said she appeared to be postictal and hallucinating. They immediately called 911 -and she was transferred to the hospital and to my knowledge she is still there. RN will keep me updated.
After she came home from her second dose, she got her period immediately; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.  A 35 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Manufacturer unknown), for COVID-19 immunization. The following information was reported: MENSTRUATION IRREGULAR (non-serious), outcome "unknown", described as "After she came home from her second dose, she got her period immediately".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
CLIENT FOUND AT DECREASED RESPONSIVENESS AT END OF HER 30 MINUTES WAIT TIME DURING MONITORING.  (MONITOR) ADVISED US SHE HAD NOT BEEN TALKING X15 MINUTES, THOUGHT SHE WAS LOOKING AT HER PHONE. CLIENT WAS NON-VERBAL AND GLASSY EYED WITH VISIBLE HIVES ON NECK AND CHEST PROGRESSING RAPIDLY DOWN BILAT. ARMS AND TORSO. O2 VIA NON-REBREATHER ON 8L STARTED. BENEDRYL 50MG GIVEN IN L. DELTIOD. 2 ROUNDS OF 0.5ML OF EPI 1:1000 GIVEN SQ IN R. ARM 15 MINUTES APART. EMS WAS NOTIFED AND ARRIVED SHORTLY AFTER 2ND ROUND OF EPI GIVEN. EMS CONTINUED CARE AT THAT TIME AND TANSFERRED HOSPITAL VIA AMBULANCE.
This spontaneous report as received from a female registered nurse reporting on herself with no drug reactions or allergies, who a week or two ago in approximately July 2013, she started to feel weird described as uncomfortableness and itchiness on the roof of her mouth. It was stated that these events occurred soon after the administration of ZOSTAVAX (dose and lot number not reported) to the patient in approximately 2013 and lasted a couple of hours. The nurse reported that she had gloves on when she reconstituted and administered ZOSTAVAX to the patient. No treatment was given for the experience. No lab diagnostics studies were performed. The patient did not seek medical attention. The relatedness for uncomfortableness and itchiness on the roof of her mouth and ZOSTAVAX was unknown. Additional information has been requested.
Rash around injection site which also appeared around the first injection site the day of the second vaccine which then grew into a large welt.  101.4 fever.  3 days after vaccine fever blister developed and lasted two weeks.
Vaccination error identified on 08/24/21 afternoon that an expired vaccine was given to the patient in the morning. Provider received advices from manufacturer that repeating 2nd dose is required. Patient received another dose on 08/28/2021.
Pericarditis; Chest constriction; Difficulty breathing; Heart Palpitations; This is a spontaneous report from a contactable consumer (patient). A 33-years-old male patient received the first dose of bnt162b2 (BNT162B2), via an unspecified route of administration, administered in right arm on 02Sep2021 (Lot Number: EW0165) at the age of 33 years as single dose for covid-19 immunisation. Medical history included known allergies: penicillin. There were no concomitant medications. No COVID prior vaccination. No other vaccine in four weeks. Patient experienced chest constriction, heart palpitations, difficulty breathing, abnormal EKG ultimately diagnosed as pericarditis on 04Sep2021. AE resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No treatment received. Covid test type post vaccination: Nasal swab Post on 06Sep2021 was negative. Outcome of events were recovered on an unspecified date in 2021.  Follow-up attempts are completed. No further information is expected.
Had shingles symptoms starting on November 14th, gradually getting worse until I saw typical shingles rash on November 18.
Following day after KINRIX and MMR, had large red area around injection site-Progressed to swelling and vessicles by day #3 after shots. Seen in clinic on 3/25 and 3/26 for evaluation-started on oral Prednisone and Benadryl for significant local hypersensitivity reaction.
During the week he complianed about chest pain, but we didn't pay any attention. On Saturday morning he was ok, went out and when he cema back he laid down. In the afternoon i woke him up and he had a fever of 102.2, blood pressure 157/96, he was shaking and desoriented. I called 911, in the ER he continue like tat. The doctor did some labs and came out negative, everything they did came out negative, he has seazures the next day and was sent to ICU. He was intubated for 4 days. The doctors said that it was a brain infection but all the test results are negative. The doctors at first thought that it was either menigitis  or encephalitis, all the test were negative . His final diagnosis was Sepsis, unspecified organism.  He still recovering  and does not have any recolection of what happened to him.
(L) upper arm with 5cm area of redness, no induration. Pt was seen 3d after shots given; Fa states redness & swelling was greater yest 7.5cm by circle measurement. Plan: warm packs.